Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-002119

ACURA PHARMACEUTICALS, INC · ACUR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 2, 2015
Accepted (ET)
Jan 6, 2015 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jan 2, 2015M11,030—A14,030D
Common StockF5,F3Jan 2, 2015F246$0.45D13,784D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF7,F2,F6—Jan 2, 2015M11,030D——Common Stock11,03025,734D
Restricted Stock UnitsF5,F8,F2,F6—Jan 2, 2015D7,352D——Common Stock7,35218,382D
Restricted Stock UnitsF7,F2,F9—Jan 2, 2015A51,546A——Common Stock51,54651,546D

Explanation of responses